GCTS

GCTS is not investable on the numbers as they stand. FY2025 revenue fell 68.6% to $2.87M — the third straight year of decline ($16.0M → $9.13M → $2.87M) — while the net loss widened 250% to -$43.4M. Gross profit is negative (-$1.82M, -63.4% margin), so the company loses money on the product itself before a dollar of the $14.0M R&D spend; operating margin is -1,275% and net margin -1,513%. This is a pre-commercial cost structure attached to a shrinking legacy 4G revenue base, and the accumulated deficit of -$605M underlines how long the cash burn has run.

The balance sheet is the disqualifier. Stockholders' equity is -$83.3M (negative and deepening), total liabilities of $98.9M dwarf $15.6M of assets, and cash is down to $590K against $56.6M of current (near-term) debt and $79.6M of current liabilities. Operating cash flow was -$30.7M. With well under $1M of cash to service tens of millions in obligations due within a year, GCTS is dependent on continuous external financing to remain a going concern — and it has been diluting aggressively to survive, with shares up 50.3% year-over-year to 72.5M. Any equity holder faces a real risk of further heavy dilution or restructuring that impairs the stock.